LitCovid-sample-Enju  

PMC:7199903 / 12727-13290 JSONTXT 16 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
T44252 0-7 IN denotes Whereas
T8171 8-11 DT denotes the
T39795 12-29 JJ denotes oligomannose-type
T73596 30-36 NN denotes glycan
T59365 37-44 NN denotes content
T99808 45-46 -LRB- denotes (
T34115 46-48 CD denotes 28
T21559 48-49 NN denotes %
T47422 49-50 -RRB- denotes )
T52753 51-52 -LRB- denotes (
T61056 52-57 NN denotes table
T40589 58-60 NN denotes S2
T96095 60-61 -RRB- denotes )
T22184 62-64 VBZ denotes is
T69759 65-70 IN denotes above
T22986 71-75 IN denotes that
T24433 76-84 VBN denotes observed
T62977 85-87 IN denotes on
T34380 88-95 JJ denotes typical
T20152 96-100 NN denotes host
T61533 101-114 NNS denotes glycoproteins
T13550 114-115 -COMMA- denotes ,
T27606 116-118 PRP denotes it
T82381 119-121 VBZ denotes is
T28293 122-127 JJR denotes lower
T56709 128-132 IN denotes than
T85625 133-138 JJ denotes other
T35332 139-144 JJ denotes viral
T47969 145-158 NNS denotes glycoproteins
T28276 160-163 IN denotes For
T16362 164-171 NN denotes example
T16646 171-172 -COMMA- denotes ,
T86047 173-176 CD denotes one
T49490 177-179 IN denotes of
T73507 180-183 DT denotes the
T59944 184-188 RBS denotes most
T25572 189-196 RB denotes densely
T28586 197-209 VBN denotes glycosylated
T97814 210-215 JJ denotes viral
T45720 216-221 NN denotes spike
T63316 222-230 NNS denotes proteins
T67493 231-233 VBZ denotes is
T5107 234-239 NN denotes HIV-1
T33765 240-243 NN denotes Env
T65352 243-244 -COMMA- denotes ,
T93662 245-250 WDT denotes which
T82020 251-259 VBZ denotes exhibits
T54543 260-263 CD denotes ~60
T27723 263-264 NN denotes %
T66901 265-282 JJ denotes oligomannose-type
T75833 283-290 NNS denotes glycans
T67860 291-292 -LRB- denotes (
T96850 292-294 CD denotes 21
T16706 294-295 -COMMA- denotes ,
T77788 296-298 CD denotes 34
T37032 298-299 -RRB- denotes )
T66377 301-305 DT denotes This
T59113 306-314 VBZ denotes suggests
T7350 315-319 IN denotes that
T84608 320-323 DT denotes the
T79579 324-334 NN denotes SARS-CoV-2
T90817 335-336 NN denotes S
T46370 337-344 NN denotes protein
T49742 345-347 VBZ denotes is
T65139 348-352 RBR denotes less
T25953 353-360 RB denotes densely
T38725 361-373 VBN denotes glycosylated
T99018 374-377 CC denotes and
T61137 378-382 IN denotes that
T86967 383-386 DT denotes the
T63886 387-394 NNS denotes glycans
T21482 395-399 VBP denotes form
T93073 400-404 JJR denotes less
T83016 405-407 IN denotes of
T33280 408-409 DT denotes a
T85733 410-416 NN denotes shield
T30140 417-425 VBN denotes compared
T50036 426-430 IN denotes with
T75732 431-436 JJ denotes other
T97967 437-442 JJ denotes viral
T29563 443-456 NNS denotes glycoproteins
T29111 456-457 -COMMA- denotes ,
T12944 458-467 VBG denotes including
T78853 468-473 NN denotes HIV-1
T41077 474-477 NN denotes Env
T98405 478-481 CC denotes and
T41548 482-486 NN denotes LASV
T28392 487-490 NN denotes GPC
T20621 490-491 -COMMA- denotes ,
T35209 492-497 WDT denotes which
T31115 498-501 MD denotes may
T83078 502-504 VB denotes be
T44859 505-515 JJ denotes beneficial
T25244 516-519 IN denotes for
T31092 520-523 DT denotes the
T2299 524-535 NN denotes elicitation
T33174 536-538 IN denotes of
T63621 539-551 VBG denotes neutralizing
T62387 552-562 NNS denotes antibodies
R10257 T61533 T62977 arg2Of glycoproteins,on
R10503 T63886 T21482 arg1Of glycans,form
R10855 T46370 T38725 arg2Of protein,glycosylated
R11827 T28586 T25572 arg1Of glycosylated,densely
R13700 T24433 T22184 arg2Of observed,is
R14261 T47422 T99808 arg3Of ),(
R14368 T47969 T56709 arg2Of glycoproteins,than
R14393 T22986 T69759 arg2Of that,above
R15990 T28293 T56709 arg1Of lower,than
R17404 T63316 T49490 arg2Of proteins,of
R17573 T63316 T28586 arg1Of proteins,glycosylated
R17628 T93073 T83016 arg1Of less,of
R17686 T63316 T97814 arg1Of proteins,viral
R19015 T62387 T63621 arg1Of antibodies,neutralizing
R19069 T77788 T16706 arg2Of 34,","
R19591 T59365 T8171 arg1Of content,the
R21364 T93073 T21482 arg2Of less,form
R21487 T21559 T99808 arg2Of %,(
R21636 T28392 T41548 arg1Of GPC,LASV
R2357 T37032 T67860 arg3Of ),(
R24004 T61533 T20152 arg1Of glycoproteins,host
R25150 T33765 T67493 arg2Of Env,is
R25417 T82381 T44252 arg1Of is,Whereas
R26595 T98405 T12944 arg2Of and,including
R27773 T24433 T69759 arg1Of observed,above
R28363 T29563 T75732 arg1Of glycoproteins,other
R2845 T50036 T30140 arg2Of with,compared
R31047 T61137 T99018 arg2Of that,and
R32128 T96850 T67860 arg2Of 21,(
R33343 T27606 T28293 arg1Of it,lower
R33489 T33765 T93662 arg1Of Env,which
R33571 T29563 T29111 arg1Of glycoproteins,","
R34491 T38725 T49742 arg2Of glycosylated,is
R34637 T47969 T35332 arg1Of glycoproteins,viral
R34663 T33765 T5107 arg1Of Env,HIV-1
R3623 T59365 T39795 arg1Of content,oligomannose-type
R37966 T59365 T22184 arg1Of content,is
R38136 T83078 T31115 arg2Of be,may
R4148 T47969 T85625 arg1Of glycoproteins,other
R41910 T75833 T54543 arg1Of glycans,~60
R42369 T40589 T61056 arg1Of S2,table
R42702 T59365 T52753 arg1Of content,(
R43307 T41077 T98405 arg1Of Env,and
R43321 T63316 T73507 arg1Of proteins,the
R45773 T98405 T44859 arg1Of and,beneficial
R49051 T85733 T33280 arg1Of shield,a
R4957 T2299 T25244 arg2Of elicitation,for
R50116 T29563 T97967 arg1Of glycoproteins,viral
R50234 T25953 T65139 arg1Of densely,less
R51875 T41077 T78853 arg1Of Env,HIV-1
R52209 T33765 T65352 arg1Of Env,","
R52990 T67493 T16646 arg1Of is,","
R53423 T82381 T13550 arg1Of is,","
R5446 T24433 T62977 arg1Of observed,on
R55420 T98405 T31115 arg1Of and,may
R55823 T28392 T98405 arg2Of GPC,and
R56034 T96095 T52753 arg3Of ),(
R56222 T38725 T99018 arg1Of glycosylated,and
R56244 T38725 T7350 arg1Of glycosylated,that
R58603 T86047 T67493 arg1Of one,is
R58686 T38725 T25953 arg1Of glycosylated,densely
R60934 T44859 T25244 arg1Of beneficial,for
R61739 T61533 T34380 arg1Of glycoproteins,typical
R63894 T44859 T83078 arg2Of beneficial,be
R64521 T96850 T16706 arg1Of 21,","
R64838 T67493 T28276 arg1Of is,For
R66091 T16362 T28276 arg2Of example,For
R66791 T63316 T45720 arg1Of proteins,spike
R69478 T75833 T66901 arg1Of glycans,oligomannose-type
R72200 T63886 T86967 arg1Of glycans,the
R72236 T54543 T27723 arg1Of ~60,%
R72516 T46370 T90817 arg1Of protein,S
R72847 T40589 T52753 arg2Of S2,(
R73912 T59365 T24433 arg2Of content,observed
R7415 T75833 T82020 arg2Of glycans,exhibits
R75177 T46370 T49742 arg1Of protein,is
R76475 T29563 T12944 arg1Of glycoproteins,including
R76881 T66377 T59113 arg1Of This,suggests
R78032 T98405 T20621 arg1Of and,","
R7869 T62387 T33174 arg2Of antibodies,of
R79137 T46370 T84608 arg1Of protein,the
R79430 T98405 T35209 arg1Of and,which
R79975 T86047 T49490 arg1Of one,of
R80841 T75833 T67860 arg1Of glycans,(
R81204 T59365 T73596 arg1Of content,glycan
R85283 T2299 T31092 arg1Of elicitation,the
R8540 T2299 T33174 arg1Of elicitation,of
R86337 T46370 T79579 arg1Of protein,SARS-CoV-2
R86704 T33765 T82020 arg1Of Env,exhibits
R86709 T99018 T59113 arg2Of and,suggests
R88890 T25572 T59944 arg1Of densely,most
R89185 T21559 T34115 arg1Of %,28
R89424 T29563 T50036 arg2Of glycoproteins,with
R89854 T98405 T83078 arg1Of and,be
R89867 T28293 T82381 arg2Of lower,is
R90386 T24433 T44252 arg2Of observed,Whereas
R9156 T59365 T99808 arg1Of content,(
R94916 T21482 T61137 arg2Of form,that
R97132 T85733 T83016 arg2Of shield,of
R98481 T59113 T30140 arg1Of suggests,compared
R99198 T27606 T82381 arg1Of it,is